Sunday, November 19, 2017
 
 
News: Page (1) of 1 - 07/22/11 Email this story to a friend. email article Print this page (Article printing at MyDmn.com).print page facebook
Correction officials turn over execution drug
US state turns over execution drug to feds amid legal questions over how it got it
By The Associated Press

LITTLE ROCK, Arkansas (AP) ' Arkansas is the latest state to surrender a key lethal-injection drug obtained from a British supplier amid legal questions about how the state got it.

The state recently gave federal officials the supply of sodium thiopental that it received from the London company Dream Pharma, Arkansas Department of Correction spokeswoman Dina Tyler said Thursday.

Sodium thiopental, a sedative in the three-drug cocktail used in lethal injections, has been hard to come by since its sole U.S. manufacturer stopped making it. That prompted Arkansas and at least half a dozen other death-penalty states to turn their attention to suppliers overseas.



The move resulted in legal challenges by attorneys for death-row inmates about whether the states circumvented the law to get the drug and whether the drug would cause an inmate unnecessary pain and suffering. The Drug Enforcement Administration seized Georgia's entire supply of the drug in March, and DEA agents later took supplies in Kentucky and Tennessee.

In those states, the seizures effectively halted executions ' if only temporarily. Georgia executed an inmate using a different drug on Thursday.

Arkansas doesn't have any scheduled executions, in part because of a lawsuit claiming that the sodium thiopental obtained from Dream Pharma could cause unnecessary suffering. But even if an execution were set, the state wouldn't be able to carry it out without finding another supplier or switching to a different drug.

The state turned over the last of its supply of sodium thiopental from Dream Pharma on July 5, according to court documents filed Thursday by Arkansas Attorney General Dustin McDaniel. McDaniel argued that the move makes part of the lawsuit's argument moot.

"The controversy the prisoners have attempted to create regarding the three alleged risks arising from sodium thiopental obtained from Dream Pharma no longer exists," the attorney general said in the court brief.

The federal public defender's office, whose lawyers represent some of the inmates, declined comment Thursday night, as did William J. Bryant, Assistant Special Agent in Charge at the DEA in Little Rock.

"With the concerns around the drug, we think it was a prudent step for the (corrections) department to take," said Matt DeCample, a spokesman for Gov. Mike Beebe.

Tyler, the prisons spokeswoman in Arkansas, said the state could find another source of sodium thiopental overseas, look to other states to borrow some or switch to another execution drug.

"Right now we're just exploring our options," she said. "We don't have any pending executions, which gives us time to figure out which direction is best for the state and the agency."

Using other drugs in lethal injections has drawn concerns, too. An inmate in Georgia claims that the state's new execution drug ' the sedative pentobarbital ' would cause him needless pain and suffering.

Arkansas hasn't put anyone to death since 2005. Aside from the question over sodium thiopental, attorneys for death-row inmates argue that legislators didn't have the authority to transfer responsibility for execution policies from the Legislature to the Department of Correction in 2009, calling the move a violation of the state Constitution.

___

Jeannie Nuss can be reached at http://twitter.com/jeannienuss


Page: 1


 
 
 
 
 
 
 
 
 
 
 





Our Privacy Policy --- About The U.S. Daily News - Contact Us - Advertise With Us - Privacy Guidelines